[Home] [Headlines] [Latest Articles] [Latest Comments] [Post] [Sign-in] [Mail] [Setup] [Help]
Status: Not Logged In; Sign In
Health See other Health Articles Title: Regeneron says antibody cocktail is effective in preventing symptomatic COVID-19 infection Ten out of 186 people who received the treatment contracted COVID-19 but did not experience symptomsRegeneron via AP Norwegian Cruise Line making COVID-19 vaccine mandatory for crew Moderna COVID-19 vaccine should not be used on pregnant women: WHO Early results on Pfizer vaccine are encouraging, Israeli HMO says Casino mogul, actress wife pose as motel workers to cut vaccine line The antibody cocktail used to treat COVID-19 has shown to be 100 percent effective at protecting against symptomatic cases of the bug, according to new data released Tuesday. Regeneron said its REGEN-COV treatment completely reduced symptomatic infections and cut overall rates of infections to about 50 percent in about 400 participants who was living with a COVID-19 patient. Ten out of 186 people who received the treatment contracted COVID-19 but did not experience symptoms. Those participants also had smaller viral loads and a shorter period of viral shedding, the company said. The Westchester-based biotechnology giant said the treatment could be used as a passive vaccine following the Phase 3 results in the trial jointly run by the National Institute of Allergy and Infectious Diseases. In November, the Food and Drug Administration greenlit Regenerons therapy for mild to moderate COVID-19 cases in adults and children. A passive vaccine involves delivering virus-fighting antibodies into the body unlike traditional vaccines which activates a persons immune system to develop their own antibodies. Full results from the trial are expected in the second quarter. Post Comment Private Reply Ignore Thread
|
||
[Home]
[Headlines]
[Latest Articles]
[Latest Comments]
[Post]
[Sign-in]
[Mail]
[Setup]
[Help]
|